Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function.

Metastatic tumor cells that actively migrate and invade surrounding tissues rely on invadopodia to degrade extracellular matrix (ECM) barriers. Invadopodia are membrane protrusions that localize enzymes required for ECM degradation. Little is known about the formation, function, and regulation of invadopodia. Here, we show that invadopodia have two distinct aspects: (a) structural for organizing the cellular actin cytoskeleton to form membrane protrusions and (b) functional for using proteolytic enzyme(s) for ECM degradation. Small interfering RNA (siRNA) inhibition established that organization of invadopodia structure requires cortactin, whereas protease inhibitor studies identified membrane type 1 matrix metalloproteinase (MT1-MMP) as the key invadopodial enzyme responsible for gelatin matrix degradation in the breast carcinoma cell line MDA-MB-231. The inhibition of invadopodial structure assembly by cortactin depletion resulted in a block of matrix degradation due to failure of invadopodia formation. Either protease inhibition or MT1-MMP siRNA depletion moderately decreased the formation of invadopodial structures that were identified as actin-cortactin accumulations at the ventral cell membrane adherent to matrix. The invadopodia that were able to form upon MT1-MMP inhibition or depletion retained actin-cortactin accumulations but were unable to degrade matrix. Examination of cells at different time points as well as live-cell imaging revealed four distinct invadopodial stages: membrane cortactin aggregation at membranes adherent to matrix, MT1-MMP accumulation at the region of cortactin accumulation, matrix degradation at the invadopodia region, and subsequent cortactin dissociation from the area of continued MT1-MMP accumulation associated with foci of degraded matrix. Based on these results, we propose a stepwise model of invadopodia formation and function.

[1]  E. Schuuring.  The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes--a review. , 1995, Gene.

[2]  Erik Sahai,et al.  Tumor cells caught in the act of invading: their strategy for enhanced cell motility. , 2005, Trends in cell biology.

[3]  M. Seiki,et al.  Roles of pericellular proteolysis by membrane type‐1 matrix metalloproteinase in cancer invasion and angiogenesis , 2003, Cancer science.

[4]  Y. Itoh,et al.  MT1-MMP: an enzyme with multidimensional regulation. , 2004, Trends in biochemical sciences.

[5]  P. Cohen,et al.  Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues. , 1986, The Journal of biological chemistry.

[6]  R. Cardiff,et al.  Induction of mammary epithelial hyperplasias and mammary tumors in transgenic mice expressing a murine mammary tumor virus/activated c-src fusion gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[7]  H. Petty,et al.  Molecular proximity of seprase and the urokinase-type plasminogen activator receptor on malignant melanoma cell membranes: dependence on beta1 integrins and the cytoskeleton. , 2002, Carcinogenesis.

[8]  H. Birkedal‐Hansen,et al.  Tumor cell-selective cytotoxicity of matrix metalloproteinase-activated anthrax toxin. , 2000, Cancer research.

[9]  S. Weed,et al.  Cortactin: coupling membrane dynamics to cortical actin assembly , 2001, Oncogene.

[10]  Jing Chen,et al.  Actin and Arf1-dependent recruitment of a cortactin–dynamin complex to the Golgi regulates post-Golgi transport , 2005, Nature Cell Biology.

[11]  C. Haudenschild,et al.  Cortactin potentiates bone metastasis of breast cancer cells. , 2001, Cancer research.

[12]  S. Akiyama,et al.  A Novel Protease-docking Function of Integrin at Invadopodia* , 1999, The Journal of Biological Chemistry.

[13]  A. Osiak,et al.  Subconfluent endothelial cells form podosomes downstream of cytokine and RhoGTPase signaling. , 2005, Experimental cell research.

[14]  W. T. Chen,et al.  A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. , 1994, Cancer research.

[15]  Paul J. Williams,et al.  C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis. , 2003, Cancer research.

[16]  E. Thompson,et al.  Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  M. Kirschner,et al.  Erk/Src Phosphorylation of Cortactin Acts as a Switch On-Switch Off Mechanism That Controls Its Ability To Activate N-WASP , 2004, Molecular and Cellular Biology.

[18]  K. Somers,et al.  Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro , 1998, Oncogene.

[19]  W. T. Chen,et al.  Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells. , 1989, The Journal of experimental zoology.

[20]  G. Rijksen,et al.  c‐Src PROTEIN EXPRESSION IS INCREASED IN HUMAN BREAST CANCER. AN IMMUNOHISTOCHEMICAL AND BIOCHEMICAL ANALYSIS , 1996, The Journal of pathology.

[21]  H. Rübsamen,et al.  Expression of pp60c-src protein kinase in adult and fetal human tissue: high activities in some sarcomas and mammary carcinomas. , 1983, Cancer research.

[22]  C. Haudenschild,et al.  The Role of Tyrosine Phosphorylation of Cortactin in the Locomotion of Endothelial Cells* , 1998, The Journal of Biological Chemistry.

[23]  D. Thomas,et al.  An invasion-related complex of cortactin, paxillin and PKCμ associates with invadopodia at sites of extracellular matrix degradation , 1999, Oncogene.

[24]  Juan P. Albar,et al.  Membrane Type 1-Matrix Metalloproteinase Is Activated during Migration of Human Endothelial Cells and Modulates Endothelial Motility and Matrix Remodeling* , 2001, The Journal of Biological Chemistry.

[25]  M. Nomizu,et al.  Activation of β1 Integrin Signaling Stimulates Tyrosine Phosphorylation of p190 RhoGAP and Membrane-protrusive Activities at Invadopodia* , 1998, The Journal of Biological Chemistry.

[26]  C. Fombrun,et al.  Matrix , 1979, Encyclopedic Dictionary of Archaeology.

[27]  Heung-Chin Cheng,et al.  Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530 , 1999, Oncogene.

[28]  W. T. Chen,et al.  Proteases associated with invadopodia, and their role in degradation of extracellular matrix. , 1996, Enzyme & protein.

[29]  Gillian Murphy,et al.  Membrane type I-matrix metalloproteinase (MT1-MMP) is internalised by two different pathways and is recycled to the cell surface , 2003, Journal of Cell Science.

[30]  J. Keski‐Oja,et al.  Regulation of Membrane-type-1 Matrix Metalloproteinase Activity by Its Cytoplasmic Domain* , 2000, The Journal of Biological Chemistry.

[31]  M. Aepfelbacher,et al.  Podosomes: adhesion hot-spots of invasive cells. , 2003, Trends in cell biology.

[32]  Claudia Castaldi,et al.  Dynamin participates in focal extracellular matrix degradation by invasive cells. , 2003, Molecular biology of the cell.

[33]  Roberto Buccione,et al.  Foot and mouth: podosomes, invadopodia and circular dorsal ruffles , 2004, Nature Reviews Molecular Cell Biology.

[34]  Alissa M. Weaver,et al.  Cortactin promotes and stabilizes Arp2/3-induced actin filament network formation , 2001, Current Biology.

[35]  C. D’Souza-Schorey,et al.  ADP-ribosylation factor 6 regulates tumor cell invasion through the activation of the MEK/ERK signaling pathway. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[36]  W. T. Chen,et al.  Binding and localization of M(r) 72,000 matrix metalloproteinase at cell surface invadopodia. , 1993, Cancer research.

[37]  Y. Onodera,et al.  Requirement for Arf6 in breast cancer invasive activities. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Steven Shapiro,et al.  Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP , 2004, The Journal of cell biology.

[39]  W. T. Chen,et al.  Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Z. Werb,et al.  Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. , 1996, Current opinion in cell biology.

[41]  S. Weiss,et al.  Membrane Type I Matrix Metalloproteinase Usurps Tumor Growth Control Imposed by the Three-Dimensional Extracellular Matrix , 2003, Cell.

[42]  J. Ward,et al.  MT1-MMP-Deficient Mice Develop Dwarfism, Osteopenia, Arthritis, and Connective Tissue Disease due to Inadequate Collagen Turnover , 1999, Cell.

[43]  M. Kogo,et al.  Involvement of Cdc42 and Rac small G proteins in invadopodia formation of RPMI7951 cells , 2003, Genes to cells : devoted to molecular & cellular mechanisms.

[44]  Hiroshi Sato,et al.  Homophilic complex formation of MT1‐MMP facilitates proMMP‐2 activation on the cell surface and promotes tumor cell invasion , 2001, The EMBO journal.

[45]  Tsutomu Ohta,et al.  Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. , 2004, Journal of hepatology.

[46]  R. Daly.  Cortactin signalling and dynamic actin networks. , 2004, The Biochemical journal.